Welcome to our October research update! Getting involved with research is an important way to impact asthma and allergy treatments, education, and awareness. This month, we are highlighting clinical trials, surveys, and news on: New treatment options for eczema, chronic spontaneous urticaria (CSU), chronic obstructive pulmonary disease (COPD), eosinophilic granulomatosis with polyangiitis (EGPA), and nasal polyps – The impact of climate change and environment on asthma and allergies – Safety of direct penicillin challenges…
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik: Asthma and Allergy Foundation of America (AAFA)
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Quick-Links
Aktuelles von Asthma and Allergy Foundation of America
- Wildfire Relief Efforts for Los Angeles Region
- AAFA Releases 2025 State Honor Roll™ Report
- Wildfires and How They Affect Air Quality and Asthma
- What You Need to Know About the $35 Price Cap on Asthma Inhalers
- AAFA’s Major Achievements in 2024
- Understanding Mild to Moderate Asthma (Video)
- December Research Update: Impact of Changing Inhaler Market on Asthma, Air Pollution, and Solar Urticaria
- Gifts to Give People with Asthma and Allergies
- How Can You Tell the Difference Between COVID-19, a Cold, the Flu, RSV, Allergies, and Asthma?
- Coronavirus (COVID-19): What People With Asthma Need to Know
